Skip to main content
SpringerLink
Log in

Treatment of Depression in Patients with Dementia

Epidemiology, Pathophysiology and Treatment

  • Disease Management
  • Published:
CNS Drugs Aims and scope Submit manuscript

Abstract

Depression is present in about 40% of patients with dementia. Whereas most studies of depression in dementia are carried out in patients with Alzheimer’s dementia, depression is also a frequent finding in other types of dementia, such as ischaemic vascular dementia, dementia with Lewy bodies and fronto-temporal dementia. Longitudinal studies have demonstrated that untreated major depressions may last for more than 1 year in patients with dementia, whereas minor depression is of shorter duration. Despite the high incidence of depression in patients with dementia, few controlled studies have examined the usefulness of antidepressant drugs. Tricyclic antidepressants (TCAs) such as imipramine and clomipramine may be effective, but a high incidence of adverse effects such as orthostatic hypotension and urinary retention may limit their use to the subgroup of patients in whom tolerability is acceptable. Selective serotonin (5-hydroxy-tryptamine; 5-HT) reuptake inhibitors (SSRIs) such as citalopram and fluoxetine have efficacy similar to that of TCAs, but the incidence of adverse effects is substantially lower. Monoamine oxidase inhibitors have rarely been assessed in patients with dementia, although moclobemide has demonstrated good efficacy and tolerability in a single study. Although antidepressant drugs usually demonstrated greater efficacy than placebo, these differences were mostly slight and require further evaluation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994

    Google Scholar 

  2. Evans DA, Funkenstein H, Albert M, et al. Prevalence of Alzheimer’s disease in a community population of older persons: higher than previous reported. JAMA 1989; 262: 2551–6

    Article  PubMed  CAS  Google Scholar 

  3. Lishman W, editor. Organic psychiatry. 3rd ed. Oxford: Blackwell Science, 1998

    Google Scholar 

  4. Price D, Thinakaran G, Borchelt D, et al. Neuropathology of Alzheimer’s disease and animal models. In: Markesbery W, editor. Neuropathology of dementing disorders. London: Arnold, 1998: 121–41

    Google Scholar 

  5. Chui HC. Dementia: a review emphasizing clinicopathologic correlation and brain behavior relationship. Arch Neurol 1989; 46: 806–14

    Article  PubMed  CAS  Google Scholar 

  6. Kosaka K, Yoshimura M, Ikeda K, et al. Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree-a new disease? Clin Neuropathol 1984; 3: 185–92

    PubMed  CAS  Google Scholar 

  7. Perry R, Irving D, Blessed G, et al. Senile dementia of Lewy body type. A clinically and neuropathologically distinct type of Lewy body dementia in the elderly. J Neurol Sci 95: 119-39

  8. Hansen L, Salmon D, Galasko D, et al. The Lewy body variant of Alzheimer’s: a clinical and pathologic entity. Neurology 1990; 40: 1–8

    Article  PubMed  CAS  Google Scholar 

  9. The Lund and Manchester Groups. Consensus statement. Clinical and neuropathological criteria for fronto-temporal dementia. J Neurol Neurosurg Psychiatry 1994; 4: 416–8

    Google Scholar 

  10. Klatka L, Louis E, Schiffer R. Psychiatric features in diffuse Lewy body disease. Neurology 1996; 47: 1148–52

    Article  PubMed  CAS  Google Scholar 

  11. Neary D, Snowden J, Gustafson L, et al. Frontotemporal lobar degeneration. A consensus on clinical diagnostic criteria. Neurology 1998; 51: 1546–54

    CAS  Google Scholar 

  12. Chemerinski E, Petracca G, Sabe L, et al. Specificity of depressive symptoms in Alzheimer’s disease. Am J Psychiatry. In press

  13. Lyketsos C, Steele C, Galik E, et al. Physical aggression in dementia patients and its relationship to depression. Am J Psychiatry 1999; 156: 66–71

    PubMed  CAS  Google Scholar 

  14. Cummings J, Miller B, Hill M, et al. Neuropsychiatric aspects of multi-infarct dementia and dementia of the Alzheimer type. Arch Neurol 1987; 44: 389–93

    Article  PubMed  CAS  Google Scholar 

  15. Lorek D, Folstein M. Depression in cerebrovascular disease. In: Starkstein S, Robinson R, editors. Depression in neurologic disease. Baltimore (MA): Johns Hopkins University Press, 1993

    Google Scholar 

  16. Migliorelli R, Teson A, Sabe L, et al. Prevalence and correlates of dysthymia and major depression among patients with Alzheimer disease. Am J Psychiatry 1995; 152: 37–44

    PubMed  CAS  Google Scholar 

  17. Lyketsos C, Steel C, Galik E, et al. Major and minor depression in Alzheimer’s disease: prevalence and impact. J Neuropsychiatry Clin Neurosci 1997; 9: 556–61

    PubMed  CAS  Google Scholar 

  18. Starkstein S, Sabe L, Vasquez S, et al. Neuropsychological, psychiatric, and cerebral blood flow findings in vascular dementia and Alzheimer’s disease. Stroke 1996; 27: 408–14

    Article  PubMed  CAS  Google Scholar 

  19. Levy M, Miller B, Cummings J, et al. Alzheimer disease and frontotemporal dementias. Arch Neurol 1996; 53: 687–90

    Article  PubMed  CAS  Google Scholar 

  20. Ballard C, Holmes C, McKeith I, et al. Psychiatric morbidity in dementia with Lewy bodies: a prospective clinical and neuropathological comparative study with Alzheimer disease. Am J Psychiatry 1999; 156: 1039–45

    PubMed  CAS  Google Scholar 

  21. Berger A, Fratiglioni L, Forsell Y, et al. The occurrence of depressive symptoms in the preclinical phase of AD. Neurology 1999; 53: 1998–2002

    Article  PubMed  CAS  Google Scholar 

  22. Chen P, Ganguli M, Mulsant B, et al. The temporal relationship between depressive symptoms and dementia. Arch Gen Psychiatry 1999; 56: 261–6

    Article  PubMed  CAS  Google Scholar 

  23. Starkstein S, Chemerinski E, Sabe L, et al. Prospective longitudinal study of depression and anosognosia in Alzheimer’s disease. Br J Psychiatry 1997; 171: 47–52

    Article  PubMed  CAS  Google Scholar 

  24. Hope T, Keene J, Fairburn C, et al. Natural history of behavioral changes and psychiatric symptoms in Alzheimer’s disease. Br J Psychiatry 1999; 174: 39–44

    Article  PubMed  CAS  Google Scholar 

  25. Brodaty H, Luscombe G. Depression in persons with dementia. Int Psychogeriatr 1996; 8(4): 609–22

    Article  PubMed  CAS  Google Scholar 

  26. Pearlson G, Ross C, Lohr W, et al. Association between family history of affective disorder and the depressive syndrome of Alzheimer’s disease. Am J Psychiatry 1990; 147: 452–6

    PubMed  CAS  Google Scholar 

  27. Lyketsos C, Tune L, Pearlson G, et al. Major depression in Alzheimer’s disease. An interaction between gender and family history. Psychosomatics 1996; 37: 380–4

    CAS  Google Scholar 

  28. Ott B, Lefleche G, Welihan W, et al. Impaired awareness of deficits in Alzheimer disease. Alzheimer Dis Assoc Disord 1996; 10: 68–76

    Article  PubMed  CAS  Google Scholar 

  29. Zweig R, Ross C, Hedreen J, et al. The neuropathology of aminergic nuclei in Alzheimer’s disease. Ann Neurol 1988; 24: 233–42

    Article  PubMed  CAS  Google Scholar 

  30. Zubenko G, Mossy J, Kopp U. Neurochemical correlates of major depression in primary dementia. Arch Neurol 1990; 47: 209–14

    Article  PubMed  CAS  Google Scholar 

  31. Hoogendijk W, Sommer I, Pool C, et al. Lack of association between depression and loss of neurons in the locus coeruleus in Alzheimer disease. Arch Gen Psychiatry 1999; 56: 45–51

    Article  PubMed  CAS  Google Scholar 

  32. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd rev. ed. Washington, DC: American Psychiatric Association, 1987

    Google Scholar 

  33. Starkstein S, Vázquez S, Migliorelli R, et al. A SPECT study of depression in Alzheimer’s disease. Neuropsychiatry Neuropsychol Behav Neurol 1995; 8: 38–43

    Google Scholar 

  34. Hirono N, Mori E, Ishii K, et al. Frontal lobe hipometabolism and depression in Alzheimer’s disease. Neurology 1998; 50: 380–3

    Article  PubMed  CAS  Google Scholar 

  35. Pozzi D, Golimstok A, Migliorelli R, et al. Quantified EEG correlates of depression in Alzheimer’s disease. Biol Psychiatry 1993; 34: 286–91

    Article  Google Scholar 

  36. Reifler B, Teri L, Raskind M, et al. Double blind trial of imipramine in AD patients with and without depression. Am J Psychiatry 1989; 146: 45–9

    PubMed  CAS  Google Scholar 

  37. Fuchs A, Hehnke U, Erhart C, et al. Video rating analysis of effect of maprotiline in patients with dementia and depression. Pharmacopsychiatry 1993; 26: 37–41

    Article  PubMed  CAS  Google Scholar 

  38. Petracca G, Teson A, Chemerinsk E, et al. A double-blind placebo-controlled study of clomipramine in depressed patients with Alzheimer’s disease. J Neuropsychiatry Clin Neurosci 1996; 8: 270–5

    PubMed  CAS  Google Scholar 

  39. Nyth A, Gottfries C. The clinical efficacy of citalopram in treatment of emotional disturbance in dementia disorders. A Nordic multicentre study. Br J Psychiatry 1990; 157: 894–901

    CAS  Google Scholar 

  40. Taragano F, Lyketsos C, Mangone C, et al. A double-blind, randomized, fixed-dose trial of fluoxetine vs amitriptyline in the treatment of major depression complicating Alzheimer’s disease. Psychosomatics 1997; 38: 246–52

    Article  PubMed  CAS  Google Scholar 

  41. Katona C, Hunter B, Bray J. A double-blind comparison of the efficacy and safety of paroxetine and imipramine in the treatment of depression with dementia. Int J Geriatr Psychiatry 1998; 13: 100–8

    Article  PubMed  CAS  Google Scholar 

  42. Roth M, Mountjoy R, Amrein R, and the International Collaborative Study Group. Moclobemide in elderly patients with cognitive decline and depression. Br J Psychiatry 1996; 168: 149–57

    Article  PubMed  CAS  Google Scholar 

  43. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed. Washington, DC: American Psychiatric Association, 1980

    Google Scholar 

  44. Teri L, Logsdon R, Uomoto J, et al. Behavioral treatment of depression in dementia patients: a controlled clinical trial. J Gerontol B Psychol Sci Soc Sci 1997; 4: 159–66

    Article  Google Scholar 

  45. Stoudemire A, Dessonville Hill C, Morris R, et al. Improvement in depression-related cognitive dysfunction following ECT. J Neuropsychiatry Clin Neurosci 1995; 7: 31–4

    PubMed  CAS  Google Scholar 

  46. Nelson J, Rosenberg D. ECT treatment of demented elderly patients with major depression: a retrospective study of efficacy and safety. Convuls Ther 1991; 7: 157–65

    PubMed  Google Scholar 

Download references

Acknowledgements

This study was partially supported by grants from the Raul Carrea Institute of Neurological Research-FLENI, and the Fundación Perez Companc.

Author information

Authors and Affiliations

  1. Department of Neuropsychiatry and Neuropsychology, Raul Carrea Institute of Neurological Research - FLENI, Montañeses 2325, 1428, Buenos Aires, Argentina

    Esteban A. Fridman &  Sergio E. Starkstein

Authors
  1. Esteban A. Fridman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sergio E. Starkstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sergio E. Starkstein.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fridman, E.A., Starkstein, S.E. Treatment of Depression in Patients with Dementia. Mol Diag Ther 14, 191–201 (2000). https://doi.org/10.2165/00023210-200014030-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00023210-200014030-00002

Keywords

Search

Navigation